INSM·457669307·US·equity·Healthcare - Biotechnology-13D/G
INSM (INSMED INC) is held by 269 institutional investors as of Q1 2026. Largest holders: JPMORGAN CHASE & CO ($3.7B), BlackRock, Inc. ($2.7B), FMR LLC ($2.2B). Net institutional sentiment: Mixed.
See how INSM's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer